Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Industry's PMS activities branded "unsatisfactory"

This article was originally published in RAJ Devices

Executive Summary

Postmarket surveillance activities by medical device manufacturers in the UK remain unsatisfactory and some companies still view their clinical trial data as private property, despite this being unethical and against trade association guidance. These were some of the key points to emerge from a meeting of medtech experts hosted by the UK Medicines and Healthcare products Regulatory Agency.

Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC095546

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel